ES2059376T3 - Plasmidos que confieren a las bacterias insensibilidad frente a los fagos. - Google Patents

Plasmidos que confieren a las bacterias insensibilidad frente a los fagos.

Info

Publication number
ES2059376T3
ES2059376T3 ES87304557T ES87304557T ES2059376T3 ES 2059376 T3 ES2059376 T3 ES 2059376T3 ES 87304557 T ES87304557 T ES 87304557T ES 87304557 T ES87304557 T ES 87304557T ES 2059376 T3 ES2059376 T3 ES 2059376T3
Authority
ES
Spain
Prior art keywords
plasmid
plasmids
phaguses
insensitivity
phage insensitivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87304557T
Other languages
English (en)
Inventor
Charles Daly
Gerald F Fitzgerald
Aidanof Ballylaneen Coffey
Andreas Baumgartner
Veronicaa Costello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Cork
Original Assignee
University College Cork
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College Cork filed Critical University College Cork
Application granted granted Critical
Publication of ES2059376T3 publication Critical patent/ES2059376T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A UN PLASMIDO DISTINTO DEL PLASMIDO EN UNA COMBINACION NATURAL HOSPEDANTE/ PLASMIDO, QUE ELEVA UNO O MAS GENES QUE CONFIEREN INSENSIBILIDAD A LOS FAGOS A LAS BACTERIAS STREPTOCOCCUS LACTIS O STERPTOCOCCUS LACTIS SUBSP. DIACETYLACTIS ASI COMO STREPTOCOCCUS CREMORIS. LA CAPACIDAD DE CONFERIR INSENSIBILIDAD A LOA FAGOS NO SE DESTRUYE POR TEMPERATURAS DE HASTA 40 GRADOS CENTIGRADOS. LOS DOS PLASMIDOS SE CARACTERIZAN EN TERMINOS DE SU SENSIBILIDAD A ENDONUCLEOSAS DE RESTRICCION. LA INVENCION ADEMAS SE REFIERE AL ADN DE DICHO PLASMIDO QUE CODIFICA LA INSENSIBILIDAD A LOS FAGOS. LAS INVENCION TAMBIEN PROPORCIONA HOSPEDANTES BACTERIANOS QUE CONTIENEN UN PLASMIDO COMO EL CITADO Y CULTIVOS INICIADORES DE ALIMENTOS QUE CONTIENEN DICHOS HOSPEDANTES BACTERIANOS.
ES87304557T 1986-05-21 1987-05-21 Plasmidos que confieren a las bacterias insensibilidad frente a los fagos. Expired - Lifetime ES2059376T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE135286A IE66528B1 (en) 1986-05-21 1986-05-21 Plasmids conferring phage insensitivity on bacteria

Publications (1)

Publication Number Publication Date
ES2059376T3 true ES2059376T3 (es) 1994-11-16

Family

ID=11025946

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87304557T Expired - Lifetime ES2059376T3 (es) 1986-05-21 1987-05-21 Plasmidos que confieren a las bacterias insensibilidad frente a los fagos.

Country Status (6)

Country Link
EP (1) EP0246909B1 (es)
AT (1) ATE95240T1 (es)
DE (1) DE3787565T2 (es)
DK (1) DK258087A (es)
ES (1) ES2059376T3 (es)
IE (1) IE66528B1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660931B1 (fr) * 1990-04-13 1994-09-02 Sanofi Sa Plasmide comprenant au moins un mecanisme de resistance aux phages bacteries le contenant et leur utilisation.
FR2708937B1 (fr) * 1993-08-09 1995-12-08 Sanofi Elf Séquence d'ADN et plasmides comprenant au moins un mécanisme de résistance aux phages, bactéries les contenant et leur utilisation.
AUPM876494A0 (en) * 1994-10-13 1994-11-03 Mauri Laboratories Pty Ltd Plasmids encoding bacteriophage resistance for use in lactic acid bacteria
DE69531539T2 (de) * 1995-06-16 2004-04-01 Société des Produits Nestlé S.A. Phagenresistenter Streptococcus
FR2737896B1 (fr) * 1995-08-18 1997-11-07 Systemes Bio Ind Sequence d'adn et plasmides comprenant au moins un mecanisme de resistance aux phases, bacteries les contenant et leur utilisation
FR2738015B1 (fr) * 1995-08-22 1997-11-14 Systems Bio Ind Sequences d'adn et plasmides comprenant au moins un mecanisme de resistance aux phases, bacteries les contenant et leur utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918014A (en) * 1985-10-11 1990-04-17 Microlife Technics, Inc. Method for producing mucoid and phage resistant group N streptococcus strains from non-mucoid and phage sensitive parent strains

Also Published As

Publication number Publication date
DE3787565T2 (de) 1994-04-14
EP0246909B1 (en) 1993-09-29
IE861352L (en) 1987-11-21
IE66528B1 (en) 1996-01-24
EP0246909A3 (en) 1988-11-30
DK258087A (da) 1987-11-22
EP0246909A2 (en) 1987-11-25
DE3787565D1 (de) 1993-11-04
ATE95240T1 (de) 1993-10-15
DK258087D0 (da) 1987-05-21

Similar Documents

Publication Publication Date Title
AU543201B2 (en) Vaccinal complex containing a specific antigen and vaccine containing it
DK458480A (da) Dna, recombinant plasmid og mikroorganisme indeholdende dette samt fremgangsmaader til fremstilling deraf
ATE107692T1 (de) Klonierung und expression einer bordetella pertussis-toxin-kodierenden dns.
IT7927524A0 (it) Proteine purificate e procedimento per la loro preparazione.
FR2518572B1 (fr) Plasmide d'expression permettant l'insertion appropriee d'adn heterologue
FI843529A0 (fi) Foerfarande foer detektering, identifiering och kvantitering av organismer och virus.
JPS57171926A (en) Vaccine
IT8019173A0 (it) Semi-articolazioni per giunti cardanici o simili.
IE801073L (en) Vaccine composition
DK139493A (da) Rekombinant plasmid, bakteriekultur transformeret dermed samt kulturens anvendelse
Hammond et al. Antigens and surface components associated with virulence of Actinomyces viscosus
SE8502162L (sv) Framstellning av protein g och/eller fragment derav
ES2059376T3 (es) Plasmidos que confieren a las bacterias insensibilidad frente a los fagos.
IL59663A0 (en) Vaccines obtained from bacterial mutant strains
FI850814A7 (fi) Proteiineja, farmaseuttisia seoksia, geenejä, vektoreita, isäntäorgan ismeja ja menetelmiä niiden tuottamiseksi.
ATE23190T1 (de) Plasmid p svh 1 und seine verwendung.
Ferrante et al. Nucleotide sequence of IS402 from Pseudomonas cepacia
GB2058082B (en) Process for decreasing the thermal stability of microbial rennet
OA09652A (en) Bioherbicide combining chemical agents and bacterial plant pathogens
FI803628L (fi) Antiallergiska och magsaor foerhindrande 1-oxo-1h-tiazolo /3,2-a/ pyrimidin-2-karboxamider och mellanprodukter foer deras framstaellning
ATE188997T1 (de) Klonierung von malaria-spezifischen dna- sequenzen:isolierung des gens für das 140 kd protein
De la Pena-Moctezuma et al. A physical map of the 85 kb virulence plasmid of Rhodococcus equi 103
IT1134606B (it) Apparecchiatura per scarnificare pelli,pellami e/o simili
ATE110777T1 (de) Thermorubin-antibiotikum widerstandsfähigkeitstragende dna-sequenz.
ATE66690T1 (de) Unikale, monogenetische streptokinase, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 246909

Country of ref document: ES